INIS
cancer
100%
drugs
100%
interactions
100%
lung cells
100%
concentration
75%
plasma
75%
doses
50%
anticoagulants
50%
patients
25%
values
25%
therapy
25%
monitoring
25%
inhibition
25%
induction
25%
proteins
25%
range
25%
breasts
25%
glycoproteins
25%
Keyphrases
Non-small Cell Lung Cancer (NSCLC)
100%
Drug Interactions
100%
Apixaban
100%
Alectinib
100%
Plasma Concentration
75%
Direct Oral Anticoagulants
50%
Older Patients
25%
Prophylactic Treatment
25%
Anticancer Treatment
25%
Protein-protein Interaction
25%
Cytochrome P450 3A4 (CYP3A4)
25%
P-glycoprotein (P-gp)
25%
Thrombophlebitis
25%
Breast Cancer Resistance Protein
25%
Medicine and Dentistry
Non Small Cell Lung Cancer
100%
Drug Interaction
100%
Apixaban
100%
Alectinib
100%
Direct Oral Anticoagulant
50%
Glycoprotein
25%
Thrombophlebitis
25%
Prophylaxis
25%
Protein Interaction
25%
CYP3A4
25%
Breast Cancer Resistance Protein
25%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Drug-Drug Interaction
100%
Apixaban
100%
Alectinib
100%
Direct Oral Anticoagulant
50%
Glycoprotein
25%
CYP3A4
25%
ABCG2
25%
Thrombophlebitis
25%
Biochemistry, Genetics and Molecular Biology
Blood Level
100%
Drug Interaction
100%
Glycoprotein
33%
Protein Interaction
33%
Anticancer
33%
CYP3A4
33%
ABCG2
33%